Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DURVALUMAB vs DUVELISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DURVALUMAB vs DUVELISIB: Safety Overview

Metric DURVALUMAB DUVELISIB
Total FAERS Reports 17,142 757
Deaths Reported 5,088 165
Death Rate 29.7% 21.8%
Hospitalizations 5,968 282
Average Patient Age 65.7 yrs 64.7 yrs
% Female Patients 35.1% 40.0%
FDA Approval Date N/A Sep 24, 2018
Manufacturer AstraZeneca Pharmaceuticals LP Secura Bio, Inc
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription